Close

Canaccord Genuity Upgrades Global Blood Therapeutics (GBT) to Buy

August 8, 2022 5:13 AM EDT
Get Alerts GBT Hot Sheet
Price: $68.49 --0%

Rating Summary:
    12 Buy, 15 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 2 | Down: 23 | New: 24
Join SI Premium – FREE

Canaccord Genuity analyst John Newman upgraded Global Blood Therapeutics (NASDAQ: GBT) from Hold to Buy with a price target of $72.00 (from $40.00).


For an analyst ratings summary and ratings history on Global Blood Therapeutics click here. For more ratings news on Global Blood Therapeutics click here.


Shares of Global Blood Therapeutics closed at $63.84 yesterday.


You May Also Be Interested In





Related Categories

Analyst PT Change, Upgrades